BIT' 13th Annual World Protein & Peptide Conference-2023

Scientific Program

Opening Ceremony & Keynote Forum

 

Opening Ceremony

Time: 09:00-09:20, July 12, 2023

   

Keynote Forum

Time: 09:20-12:00, July 12, 2023

Moderator

TBD

Time

Speeches and Speakers

09:20-09:30

Moderator’s Introduction

09:30-09:55

Title: Cell-penetrating Peptides and Drug Delivery
Dr. Ulo Langel, Professor, Stockholm University, Sweden
Member of the Academia Europaea
Foreign Member of Estonian Academy of Science

09:55-10:20

Title: Genomes, Structural Biology and Drug Discovery: Combating the Impacts of Mutations in Genetic Disease and Antibiotic Resistance
Dr. Tom Blundell, Professor, Department of Biochemistry, University of Cambridge, UK
Member of Academia Europaea; Fellow of the Royal Society
Fellow of Academy of Medical Sciences

10:20-10:45

Title: How Spearheading Cell & Gene Therapy Changes Our Innovation Model in Pharma
Dr. Wolfram Carius, Executive Vice President of Cell and Gene Therapy, Pharmaceuticals Division, Bayer Pharmaceuticals, Germany

10:45-11:10

Title: Modification of Proteins to Vaccines
Dr. Gaiping Zhang, President, Henan Agricultural University, China

11:10-11:35

Title: From Informatics to Intelligence: Bioinformatics, Bioengineering, and Brain Science
Dr. Matthew He, Professor & Director, Nova Southeastern University, USA

11:35-12:00

Title: Protein-DNA Recognition and Target Location Studied by NMR Spectroscopy
Dr. Robert Kaptein, Emeritus Professor, Bijvoet Center for Biomolecular Research, Utrecht University, The Netherlands

 

Nexus 1: Philosophy of Life’s Carriers 

 

Nexus 1-1: Novel Protein Expression Systems and Post Translational Modifications

Time: Afternoon, July 12, 2023

Chair

Call for Chair

Time

Speeches and Speakers

13:30-13:35

Chair’s Introduction

13:35-14:00

Speech Opportunity Available

14:00-14:25

Speech Opportunity Available

14:25-14:50

Title: TBD
Bismark Akuoko Nketia, Supervisor, SAT Corporation, South Africa

14:50-15:15

Speech Opportunity Available

15:15-15:30

Coffee Break

  

Nexus 1-2: Frontiers of Protein Structures, Self-Assembly and Functions

Time: Morning, July 13, 2023

Chair

Dr. Xu-Biao Peng, Assistant Professor, Beijing Institute of Technology, China

Time

Speeches and Speakers

08:30-08:35

Chair’s Introduction

08:35-09:00

Title: Kinetics of Protein Self Assembly
Dr. Maria Ott, Martin-Luther-University Halle, Germany

09:00-09:25

Title: The Dynamics in the Photocycle of the Rhodopsin Mimic
Dr. Xu-Biao Peng, Assistant Professor, Beijing Institute of Technology, China

09:25-09:50

Title: The Prediction of Secondary Structures of Proteins with Deep Learning Algorithms
Dr. Irfan Kosesoy, Assistant Professor, Yalova University, Turkey

09:50-10:15

Speech Opportunity Available

10:15-10:30

Coffee Break

  

Nexus 1-3: Protein-Protein, Protein-DNA/RNA Interactions

Time: Afternoon, July 13, 2023

Chair

Dr. Daniel Some, Principal Scientist, Wyatt Technology Corporation, USA

Time

Speeches and Speakers

13:30-13:35

Chair’s Introduction

13:35-14:00

Speech Opportunity Available

14:00-14:25

Title: Characterization of Protein-Protein and Protein-Nucleic Acid Interactions with Light Scattering
Dr. Daniel Some, Principal Scientist, Wyatt Technology Corporation, USA

14:25-14:50

Title: Energy Metabolism Disorder Mediated Ammonia Gas-induced Autophagy via AMPK/mTOR/ULK1-Beclin1 Pathway in Chicken Livers
Dr. Xiaohua Teng, Professor, College of Animal Science and Technology, Northeast Agricultural University, China

14:50-15:15

Speech Opportunity Available

15:15-15:30

Coffee Break

  

Nexus 2: The Nature Is a Pharmacist or a Doctor

 

Nexus 2-1: New Proteins-based Drug Targets

Time: Afternoon, July 12, 2023

Chair

Dr. Marcel Blommers, CSO, Saverna Therapeutics, Switzerland

Time

Speeches and Speakers

13:30-13:35

Chair’s Introduction

13:35-14:00

Title: Antibody Therapy against Soluble Protein Targets in Cancer
Dr. Francesc Mitjans,
Chief Scientific Officer, Lykera Biomed, USA

14:00-14:25

Title: Efficient Early Drug Discovery of RNA Drug Targets Using NMR and Machine Learning
Dr. Marcel Blommers,
CSO, Saverna Therapeutics, Switzerland

14:25-14:50

Title: Breg Cells as Biomarkers of BOS
Dr. Sophie Brouard,
Director of Research, CNRS, France

14:50-15:15

Title: TBD
Dr. Zhihui Huang, Yellow Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences, China

15:15-15:30

Coffee Break

15:30-15:55

Title: The Plausibility of Neutron Biological Interactions
Dr. Joshua D. Rizak, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China

15:55-16:20

Speech Opportunity Available

 

Nexus 2-2: Protein as Biomarkers for Diagnostics

Time: Afternoon, July 13, 2023

Chair

Call for Chair

Time

Speeches and Speakers

13:30-13:35

Chair’s Introduction

13:35-14:00

Title: Semicarbazide-Sensitive Amine Oxidase" (SSAO): A Biomarker or a Target To Treat Diseases
Dr. Nathalie Auchet Mercier, Universite de Lorraine - Faculte de Medecine, France

14:00-14:25

Speech Opportunity Available

14:25-14:50

Title: Screening Peptide Biomarkers for Colorectal Cancer Patients Using Proteomics Combine Bioinformatic Analysis
Dr. Baojun Duan, Xi'an Jiaotong University, Shaanxi Provincial People's Hospital, China

14:50-15:15

Speech Opportunity Available

15:15-15:30

Coffee Break

  

Nexus 2-3: Protein Drugs for Genetic, Hormonal, Metabolic and Immunologic Disorders

Time: Morning, July 14, 2023

Chair

Dr. Snehasikta Swarnakar, Senior Principal Scientist, CSIR-Indian Institute of Chemical Biology, India

Time

Speeches and Speakers

08:30-08:35

Chair’s Introduction

08:35-09:00

Speech Opportunity Available

09:00-09:25

Title: An Insight into the Activity of Matrix Metalloprotease 7 and 13 in Inflammation and Invasiveness
Dr. Snehasikta Swarnakar, Senior Principal Scientist, CSIR-Indian Institute of Chemical Biology, India

09:25-09:50

Title: TBD
Dr. Yu Yu, Senior Research Fellow, Curtin University, USA

09:50-10:15

Speech Opportunity Available

10:15-10:30

Coffee Break

  

Nexus 2-4: Protein Therapy for Cancer & Hematological Disorders

Time: Morning, July 14, 2023

Chair

Dr. Anthony J. Berdis, Professor, Cleveland State University, USA

Time

Speeches and Speakers

08:30-08:35

Chair’s Introduction

08:35-09:00

Title: New Generation of Nanoliposome for Prevention and Traitement of Cancer and Neurodegenerative Diseases
Dr. Elmira Arab-Tehrany,
Professor, Institut National Polytechnique de Lorraine, France

09:00-09:25

Title: Targeting Enzymes Involved in DNA Repair, Recombination and Translesion DNA Synthesis in Oncology
Dr. Anthony J. Berdis, Professor, Cleveland State University, USA

09:25-09:50

Title: Plant Virus Nanoparticles and the Immune Response
Dr. Kathleen Hefferon, Visiting Professor, University of Toronto, Canada

09:50-10:15

Speech Opportunity Available

10:15-10:30

Coffee Break

 

Nexus 3: Art of ConstructingLiving Molecules

Nexus 3-1: Protein Nanotechnology

Time: Morning, July 13, 2023

Chair

Dr. Zdenek Futera, University of South Bohemia, Czech Republic

Time

Speeches and Speakers

08:30-08:35

Chair’s Introduction

08:35-09:00

Title: The Role of Enzymes in the Synthesis of Bionanoparticles
Dr. Jenny M. Blamey, Member of the Board, Chief Scientific Officer, Swissaustral USA, USA

09:00-09:25

Title: Structural and Electronic Interactions of Amino Acids, Peptides, and Proteins with Metal Surfaces
Dr. Zdenek Futera, University of South Bohemia, Czech Republic

09:25-09:50

Title: Spin Crossover Dynamical Effects for the Dioxygen Binding and Activation on Enzymes and Model Complexes
Dr. Likai Du, Associate Professor, Huazhong Agricultural University, China

09:50-10:15

Title: Mercury Sensing Using Human Serum Albumin Protein Templated Gold Nanoclusters
Dr. Subhajit Chakraborty, Indian Institute of Science Education and Research (IISER) Bhopal, India

10:15-10:30

Coffee Break

10:30-10:55

Title: TBD
Dr. Claire Loison, CNRS - Lyon University, France

10:55-11:20

Speech Opportunity Available

11:20-11:45

Speech Opportunity Available

11:45-12:10

Speech Opportunity Available

 

  

Nexus 3-2: Protein Designs and Synthesis

Time: Afternoon, July 12, 2023

Chair

Dr. Cynthia Xia, Senior Manager, Branding & PR, YouKuai Group International, China

Time

Speeches and Speakers

13:30-13:35

Chair’s Introduction

13:35-14:00

Speech Opportunity Available

14:00-14:25

Title: TBD
Dr. Cynthia Xia, Senior Manager, Branding & PR, YouKuai Group International, China

14:25-14:50

Title: Supercomputer Modeling of Key Brain Enzymes. FNR Tomography and MR Sectroscopy
Dr. Sergei D. Varfolomeev, Professor,  Emanuel Institute of Biochemical Physics, Russian Academy of Sciences, Russia

14:50-15:15

Speech Opportunity Available

15:15-15:30

Coffee Break

  

Nexus 3-3: Protein Engineering, Optimizing Expression and Purification

Time: Afternoon, July 13, 2023

Chair

Dr. Richard Fox, Co-Founder & CEO/CTO, Infinome Biosciences, USA                                                                    

Time

Speeches and Speakers

13:30-13:35

Chair’s Introduction

13:35-14:00

Title: Rapid, Massively Scalable Engineering of Proteins, Pathways, And Genomes for the Efficient Manufacturing Of Bioproducts
Dr. Richard Fox, Co-Founder & CEO/CTO, Infinome Biosciences, USA

14:00-14:25

Speech Opportunity Available

14:25-14:50

Speech Opportunity Available

14:50-15:15

Speech Opportunity Available

15:15-15:30

Coffee Break

  

Nexus 4: New Paths to Life Science Breakthroughs

 

Nexus 4-1: Next Generation Proteomics

Time: Morning, July 13, 2023

Chair

Call for Chair

Time

Speeches and Speakers

08:30-08:35

Chair’s Introduction

08:35-09:00

Speech Opportunity Available 

09:00-09:25

Speech Opportunity Available

09:25-09:50

Title: TBD
Dr. Bauerova-Hlinkova V, Slovak Academy of Sciences, Slovakia

09:50-10:15

Speech Opportunity Available

10:15-10:30

Coffee Break

  

Nexus 4-2: Membrane and Cellular Proteins

Time: Afternoon, July 13, 2023

Chair

Dr. Hongli Hu, Assistant Professor, Chinese University of Hong Kong (ShenZhen), China

Time

Speeches and Speakers

13:30-13:35

Chair’s Introduction

13:35-14:00

Speech Opportunity Available

14:00-14:25

Title: Cryo-EM Studies of GPCR with Their Signaling Proteins
Dr. Hongli Hu, Assistant Professor, Chinese University of Hong Kong (ShenZhen), China

14:25-14:50

Speech Opportunity Available

14:50-15:15

Speech Opportunity Available

15:15-15:30

Coffee Break

  

Nexus 4-3: Protein Therapeutics R & D

Time: Morning, July 14, 2023

Chair

Dr. Immanuel Lerner, CEO, Pepticom LTD, Israle

Time

Speeches and Speakers

08:30-08:35

Chair’s Introduction

08:35-09:00

Title: Potential Applications for Immune-Boosting Peptides
Dr. Michael Agrez, CEO, InterK Peptide Therapeutics Limited, Australia
09:00-09:25 Title: Application of Artificial Intelligence in Peptide Drug Discovery: Opportunities and Challenges
Dr. Immanuel Lerner, CEO, Pepticom LTD, Israle

09:25-09:50

Title: Therapeutic Potential of GnRH in Nervous System Injuries
Dr. Denisse Calderon Vallejo, Profesor, Universidad Autonoma de Aguascalientes, Mexico

09:50-10:15

Title: Data Driven Charge Transfer Altas Provides Topological View of Electronic Structure Properties for Arbitrary Proteins Comples
Dr. Fang Liu, Binzhou University, China

10:15-10:30

Coffee Break

10:30-10:55

Title: In Silico Studies of Insect Peptide Hormones and Their Receptors
Dr. Graham E Jackson, Professor Emeritus, University of Cape Town, South Africa

10:55-11:20

Speech Opportunity Available

11:20-11:45

Speech Opportunity Available

11:45-12:10

Speech Opportunity Available

 

Nexus 5: Pushing the Boundaries of Peptide Science

 

Nexus 5-1: Peptide Chemistry, Synthesis and Biosynthesisy

Time: Afternoon, July 13, 2023

Chair

Dr. Lidija Barisic, Professor, University of Zagreb, Croatia

Time

Speeches and Speakers

13:30-13:35

Chair’s Introduction

13:35-14:00

Title: Peptidomimetics Based on the Structural Features of Cyclopropane
Dr. Satoshi Shuto, Professor, Hokkaido University, Japan

14:00-14:25

Title: Conformational Properties and Biological Activity of Ferrocene Peptides
Dr. Lidija Barisic, Professor, University of Zagreb, Croatia

14:25-14:50

Title: Photopharmacology that Makes Use of Natural Peptides for that Purpose
Dr. Michel De Waard, Group Leader, L'unité de recherche de l'institut du thorax, France

14:50-15:15

Title: TBD
Dr. Mingquan Huang, Professor, Beijing Technology and Business University, China

15:15-15:30

Coffee Break

15:30-15:55

Title: Muscle and Brain Changes of Calcitonin Gene-related Peptide in Experimentally Induced Unilateral Rat Masseter Myositis
Dr. Joakim A Waldemarson, Research Director, Karolinska Institute, Sweden

15:55-16:20

Speech Opportunity Available

  

Nexus 5-2: Emerging Peptide-based Technologies

Time: Morning, July 14, 2023

Chair

Dr. Jan Kristek, Head, Karlovarske Imunologicke Centrum, Czech Republic

Time

Speeches and Speakers

08:30-08:35

Chair’s Introduction

08:35-09:00

Title: Amyloid Peptide and Protein Materials
Dr. Gang Wei, Professor, University of Bremen, Germany

09:00-09:25

Title: New Approach to Treatment of Covid-19 Infection - Antivirotics with Broad Spectrum Based on Sanger Sequencing Method
Dr. Jan Kristek, Head, Karlovarske Imunologicke Centrum, Czech Republic

09:25-09:50

Title: Numaswitch - An Efficient Production Platform to Produce Peptides and Small Proteins
Dr. Christian Schwarz, CEO and Co-Founder, Numaferm GmbH, Germany

09:50-10:15

Speech Opportunity Available

10:15-10:30

Coffee Break

 

 

Online Registration
News Release

● Call for Session Chairs, Speakers and Attendees
● Speaking Proposals are Now being Accepted
● REGISTER NOW to Secure Your Attendance 
● Call for Collaborative Partners, Medias and Journals

Hosting Organization

World High Technology Society

Copyright © 2003-2023 BIT Congress Inc
Contact Us:Email: nina@bitcongress.com